These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5692291)

  • 1. [Metabolism of drugs. 58. Metabolism of butylaminoantipyrine].
    Yoshimura H; Shimeno H; Tsukamoto H
    Yakugaku Zasshi; 1968 Jan; 88(1):89-93. PubMed ID: 5692291
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of drugs. LIX. A new metabolite of antipyrine.
    Yoshimura H; Shimeno H; Tsukamoto H
    Biochem Pharmacol; 1968 Aug; 17(8):1511-6. PubMed ID: 5672814
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of drugs. LXX. Further study on antipyrine metabolism.
    Yoshimura H; Shimeno H; Tsukamoto H
    Chem Pharm Bull (Tokyo); 1971 Jan; 19(1):41-5. PubMed ID: 5544367
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human.
    Stafford M; Kellermann G; Stillwell RN; Horning MG
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):593-606. PubMed ID: 4418208
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutical studies on 4-(aminoethanesulfonylamino)antipyrine and related compounds. I.
    Naito SI; Ueno Y; Yamaguchi H; Nakai T
    J Pharm Sci; 1971 Feb; 60(2):245-9. PubMed ID: 4396715
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism of drugs. LXXVII. In vitro metabolism of antipyrine].
    Shimeno H; Yoshimura H
    Yakugaku Zasshi; 1972 Nov; 92(11):1376-9. PubMed ID: 4675502
    [No Abstract]   [Full Text] [Related]  

  • 7. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.
    Bässmann H; Böttcher J; Schüppel R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):203-5. PubMed ID: 522906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on doping test by gas liquid chromatography-mass spectrometry. II. Detection and identification of antipyrine and its metabolites in horse urine].
    Momose A; Tsuji T
    Yakugaku Zasshi; 1972 Feb; 92(2):193-7. PubMed ID: 5063938
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood and urine concentrations following intake of propyphenazone].
    Moosmayer A; Besserer K
    Beitr Gerichtl Med; 1982; 40():335-9. PubMed ID: 7165655
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolism of isopropylantipyrine in the rat and man.
    Tateishi M; Shimizu H
    Xenobiotica; 1976 Apr; 6(4):207-15. PubMed ID: 936642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological activities of isopropylantipyrine derivatives, ephedrine-isopropylantipyrine and metabolism of its tritium labeled compound (author's transl)].
    Aonuma S; Koamay Y; Chen I; Yashiki S
    Yakugaku Zasshi; 1975 Feb; 95(2):151-61. PubMed ID: 1170294
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat.
    Böttcher J; Bässmann H; Schüppel R
    J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation and urinary pattern of 4,4'-dihydroxy-antipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and rat.
    Böttcher J; Bässmann H; Schüppel R
    J Pharm Pharmacol; 1982 Mar; 34(3):168-75. PubMed ID: 6121894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and oxidative metabolism of antipyrine in the rat.
    Aarbakke J
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):64-8. PubMed ID: 707125
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of sulfates in antipyrine metabolism in man, rat, and rabbit.
    Böttcher J; Bässmann H; Schüppel R
    Drug Metab Dispos; 1982; 10(1):90-1. PubMed ID: 6124392
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of the method of fluosol-DA administration on antipyrine metabolism in the rat.
    Shrewsbury RP; White LG
    J Pharm Pharmacol; 1990 Nov; 42(11):813-6. PubMed ID: 1982312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of drugs. LVII. Isolation, characterization and identification of p-nitrophenoxy acetic acid, a metabolite of butyl p-nitrophenyl ether in rats, mice and guinea pigs.
    Yoshimura H; Ida S; Tsuji H; Mori M; Tsukamoto H
    Biochem Pharmacol; 1967 Oct; 16(10):1953-65. PubMed ID: 6065960
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of cytochrome P-450 mediated metabolism of antipyrine in the rat at different extents of fluosol-DA hemodilution.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):411-4. PubMed ID: 2343186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine metabolism in the rat by three hepatic monooxygenases.
    Inaba T; Lucassen M; Kalow W
    Life Sci; 1980 Jun; 26(23):1977-83. PubMed ID: 7401910
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.